Product Information

OMEPRAZOLE-BICARB 40-1,680 PKT is a generic product labeled by Strides Pharma Inc., priced at $8.6356 per EA under NDC 64380018302. Its NADAC has been published 153 times since Dec 20, 2023.

FDA first approved this application on Apr 19, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the omeprazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

OMEPRAZOLE-BICARB 40-1,680 PKT

omeprazole
$8.6356per EA
High Outlier

Strength

40; 1680 mg/1720mg; mg/1720mg

NDC

64380018302

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA079182

FDA Approved

4/19/2013

TE Code

AB

On Market Since

10/1/2022

Pharmacological Classes

Alkalinizing Activity
Cytochrome P450 2C19 Inhibitors
Proton Pump Inhibitor
Proton Pump Inhibitors

Price Statistics

The NADAC for OMEPRAZOLE-BICARB 40-1,680 PKT has been published 153 times since Dec 20, 2023, and over the history we have for it it has declined 34.5%. The table below summarizes its recorded NADAC range and movement.

Current price$8.6356 per EA
All-time high$18.3077 (Jun 12, 2024)
All-time low$7.9041 (Sep 23, 2026)
52-week high$10.1411
52-week low$7.9041
Median price$10.3967
Average price$11.5054
Largest weekly change+18.7% (Apr 17, 2024)
Weeks tracked153
Tracking sinceDec 20, 2023

Price History

1W

+4.4%

1M

+9.3%

3M

+3.6%

6M

-9.5%

1Y

-14.8%

3Y

N/A

5Y

N/A

All

-34.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the omeprazole market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OMEPRAZOLE-BICARB 40-1,680 PKT?

The current National Average Drug Acquisition Cost (NADAC) for OMEPRAZOLE-BICARB 40-1,680 PKT, manufactured by Strides Pharma Inc., is $8.6356 per EA (NDC 64380018302), effective Nov 18, 2026.

How has the price of OMEPRAZOLE-BICARB 40-1,680 PKT changed over time?

Over the history we have for it, the NADAC for OMEPRAZOLE-BICARB 40-1,680 PKT has declined 34.5%. It has been tracked across 153 weekly CMS publications since Dec 20, 2023.

What are the highest and lowest recorded NADAC prices for OMEPRAZOLE-BICARB 40-1,680 PKT?

Since Dec 20, 2023, the NADAC for OMEPRAZOLE-BICARB 40-1,680 PKT has ranged from a low of $7.9041 (Sep 23, 2026) to a high of $18.3077 (Jun 12, 2024), with a median of $10.3967 per EA.

Are there cheaper alternatives to OMEPRAZOLE-BICARB 40-1,680 PKT?

No other NADAC-published product currently shares the active ingredient and strength of OMEPRAZOLE-BICARB 40-1,680 PKT in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures OMEPRAZOLE-BICARB 40-1,680 PKT?

OMEPRAZOLE-BICARB 40-1,680 PKT (NDC 64380018302) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.